MENU

Fox Chase Cancer Center News

“Most cysts won’t turn into cancer. However, because of the risk, many patients may consider surgery. It’s a big operation and we want to make sure that only those patients at the greatest cancer risk get surgery,” Weinberg said.
January 16, 2020

Multicenter Pancreatic Cyst Trial Headed by Fox Chase Researcher Launches

PHILADELPHIA (January 16, 2020)—An eight-year multicenter trial to study how often and how fast pancreatic cysts progress to cancer is launching today. Fox Chase Cancer Center serves as the headquarters for the project, although the trial is open to participation at hundreds of sites around the country.

The American Lung Association’s Lung Cancer Discovery Award, a $100,000 grant to research epigenetic factors affecting lung cancer.
January 14, 2020

Johnathan R. Whetstine Awarded Lung Cancer Discovery Award

PHILADELPHIA (January 14, 2020) – Johnathan R. Whetstine, PhD, a program leader for the Cancer Epigenetics Program at Fox Chase Cancer Center, was awarded the American Lung Association’s Lung Cancer Discovery Award, a $100,000 grant to research epigenetic factors affecting lung cancer.

Patients who had enucleoresection as compared to both enucleation and resection had greater risk for positive surgical margins.
January 10, 2020

Surgical Technique for Renal Mass Removal Affected Complications, Outcomes

PHILADELPHIA (January 10, 2020) – Patients who had enucleoresection as compared to both enucleation and resection had greater risk for positive surgical margins.

Jeffrey Farma is a surgical oncologist specializing in colorectal cancer, sarcomas, gastrointestinal stromal tumors, and skin cancer.
January 7, 2020

Farma Elected to Board of Trustees of PA Medical Society

PHILADELPHIA (January 7, 2020) – Jeffrey Farma, MD, FACS, chief of the Division of General Surgery at Fox Chase Cancer Center, was elected to the Board of Trustees by the House of Delegates of the Pennsylvania Medical Society. One of 14 trustees to be elected, Farma was selected to serve as Surgical Specialty Trustee for a term of four years.

“When people use the term ‘local recurrence,’ everyone uses it differently,” Uzzo said. “We developed a framework for people to define what local recurrence means, and then we looked to see whether local recurrence is associated with better or worse survival.”
January 7, 2020

New Classification System Could Better Define Local Recurrence of Kidney Cancers

PHILADELPHIA (January 7, 2020) – Using data from the largest national adjuvant clinical trial in kidney cancer conducted to date, researchers at Fox Chase Cancer Center have developed a novel classification system for local recurrence after surgery for renal cell carcinoma.

January 6, 2020

Pilot Project Competition Awards Announced

PHILADELPHIA (January 6, 2020) – Fox Chase Cancer Center has announced the results of this year’s Pilot Project competition, which is supported in large part by the generosity of donors attending the center’s signature fundraising event, In Vino Vita.

Margaret von Mehren, MD
January 3, 2020

Fox Chase Team Awarded Grant to Research Rare GI Tumors

PHILADELPHIA  (January 3, 2020) – Margaret von Mehren, MD,  and Lori Rink, PhD, have been awarded a two-year $270,000 grant to continue their research into PDGFRA-mutated gastrointestinal stromal tumors (GIST).

Reimann Research Building
January 2, 2020

Fox Chase Cancer Center Junior Investigators Win Awards for Pilot Projects

PHILADELPHIA (January 2, 2020) – The purpose of the Institutional Research Grant is to provide seed money for the initiation of promising new projects by newer investigators so they can obtain preliminary results that will enable them to compete successfully for national research grants. The Special Interest Award provides support for psychosocial and behavioral research, health policy or health services research, cancer in the poor and medically underserved, and childhood cancer.

Pages

Connect with Fox Chase